---
title: "Aptus Pharma Ltd (544529) — Share Price, Financials & Analysis"
symbol: "544529"
company: "Aptus Pharma Ltd"
canonical: "https://tapetide.com/stocks/544529"
isin: "INE15XJ01010"
nse_symbol: "APTUSPHARMALTD"
bse_code: "544529"
sector: "Consumer Goods"
industry: "Household Appliances"
market_cap_cr: 571.5
generated_at: "2026-09-13T18:58:27.377Z"
---

# Aptus Pharma Ltd (544529)

Canonical page: https://tapetide.com/stocks/544529

## Company

- **NSE Symbol:** APTUSPHARMALTD
- **BSE Code:** 544529
- **ISIN:** INE15XJ01010
- **Sector:** Consumer Goods
- **Industry:** Household Appliances
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2025-09-30
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** aptus-pharma.com

## About

Incorporated in 2010, Aptus Pharma Ltd is engaged in the business of marketing and distribution of finished pharmaceutical formulations.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:47:08.811989Z.

- **Market Cap:** ₹571.5 Cr
- **Classification:** SME
- **P/E (reported):** 0
- **Book Value:** ₹13.61
- **Price to Book:** 24.48
- **Dividend Yield:** 0%
- **ROE:** 19.79%
- **ROCE:** 29.6%
- **Debt to Equity:** 0.31
- **Revenue (yearly):** ₹46.7 Cr
- **Net Income:** ₹4.6 Cr
- **EBITDA:** ₹7.6 Cr
- **52-Week High:** ₹341.7
- **52-Week Low:** ₹32.32
- **RSI (14):** 71

## Tapetide Score

- **Score:** 54 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Rising
- **Percentile:** 65.6 (of 4473 scored stocks)
- **Confidence:** 81%
- **Data coverage:** 62%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 71.6 | 9% |
| growth | 98.9 | 9% |
| momentum | 98.88 | 12% |
| ownership | 48.6 | 24% |
| quality | 47.65 | 22% |
| valuation | 21.73 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has reduced debt.
- Company has a good return on equity (ROE) track record: 3 Years ROE 40.8%

### Weaknesses

- Stock is trading at 25.0 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 99.8 to 147 days.
- Working capital days have increased from 73.4 days to 117 days

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | -204.35% | -158.06% | -524.24% |
| ebitda margin growth | -18.85% | 84.64% | — |
| net income growth | 48.39% | 190% | — |
| revenue growth | 89.84% | 50% | — |
| roce | -37.54% | 28.47% | — |
| roe | -55.53% | 36.49% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Sales | 9.76 | 14.8 | 14.38 | 32.2 |
| Expenses | 7.78 | 11.93 | 11.45 | 27.7 |
| Operating Profit | 1.98 | 2.87 | 2.93 | 4.5 |
| OPM % | 20.29 | 19.39 | 20.38 | 13.98 |
| Other Income | 0 | 0.08 | 0.01 | 0.12 |
| Interest | 0.11 | 0.36 | 0.43 | 0.35 |
| Depreciation | 0.11 | 0.15 | 0.16 | 0.25 |
| Profit before tax | 1.76 | 2.44 | 2.35 | 4.02 |
| Tax % | 25.57 | 26.23 | 25.53 | 28.61 |
| Net Profit | 1.31 | 1.79 | 1.75 | 2.87 |
| EPS in Rs | 5.24 | 1.43 | 1.02 | 1.67 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Sales | 13.9 | 17.81 | 24.56 | 46.56 |
| Expenses | 13.28 | 16.27 | 19.71 | 39.11 |
| Operating Profit | 0.62 | 1.54 | 4.85 | 7.45 |
| OPM % | 4.46 | 8.65 | 19.75 | 16 |
| Other Income | 0 | 0.03 | 0.08 | 0.13 |
| Interest | 0.14 | 0.24 | 0.47 | 0.8 |
| Depreciation | 0.18 | 0.21 | 0.27 | 0.41 |
| Profit before tax | 0.3 | 1.12 | 4.19 | 6.37 |
| Tax % | 33.33 | 28.57 | 26.01 | 27.47 |
| Net Profit | 0.19 | 0.8 | 3.1 | 4.62 |
| EPS in Rs | 2.38 | 10 | 2.48 | 2.69 |
| Dividend Payout % | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Equity Capital | 0.3 | 0.3 | 5 | 6.86 |
| Reserves | 0.67 | 1.47 | 1.97 | 16.49 |
| Borrowings | 2.22 | 5.31 | 10.36 | 7.18 |
| Other Liabilities | 3.02 | 2.95 | 4.59 | 13.01 |
| Total Liabilities | 6.21 | 10.03 | 21.92 | 43.54 |
| Fixed Assets | 0.52 | 0.63 | 0.99 | 2.77 |
| CWIP | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| Other Assets | 5.69 | 9.4 | 20.93 | 40.77 |
| Total Assets | 6.21 | 10.03 | 21.92 | 43.54 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Cash from Operating Activity | -0.18 | -2.17 | -1.84 | -5.6 |
| Cash from Investing Activity | -0.35 | -0.3 | -0.54 | -6.37 |
| Cash from Financing Activity | 0.81 | 2.86 | 6.68 | 7.79 |
| Net Cash Flow | 0.28 | 0.38 | 4.3 | -4.19 |
| Free Cash Flow | -0.53 | -2.5 | -2.46 | -7.79 |
| CFO/OP | -10 | -119 | -15 | -59 |

### Ratios

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Debtor Days | 63.02 | 68.66 | 83.82 | 147.07 |
| Inventory Days | 176 | 183.57 | 285.06 | 231.78 |
| Days Payable | 104.07 | 72.25 | 52.89 | 139.37 |
| Cash Conversion Cycle | 134.95 | 179.97 | 315.98 | 239.47 |
| Working Capital Days | 51.99 | 67.02 | 36.41 | 116.81 |
| ROCE % | — | 26.48 | 38.18 | 29.96 |

## Shareholding Pattern

### Quarterly

| Category | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- |
| Promoters | 72.89% | 72.89% | 72.89% | 72.89% | 72.89% |
| FIIs | 10.03% | 10.03% | 0% | 0% | 0% |
| DIIs | 2.8% | 2.8% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 11.55% | 11.55% | 22.97% | 23.47% | 24.03% |
| Others | 2.74% | 2.74% | 4.14% | 3.64% | 3.08% |
| No. of Shareholders | 9 | 9 | 302 | 337 | 686 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 2 / 4

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 324.53 | Buy |
| EMA (10) | 325.84 | Buy |
| SMA (20) | 309.25 | Buy |
| EMA (20) | 312.31 | Buy |
| SMA (50) | 277.46 | Buy |
| EMA (50) | 281.66 | Buy |
| SMA (100) | 236.44 | Buy |
| EMA (100) | 240.99 | Buy |
| SMA (200) | 163.77 | Buy |
| EMA (200) | 168.84 | Buy |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 73.34 | Sell |
| MACD (12,26,9) | 17.54 | Buy |
| Stochastic (14,3,3) | 92.26 | Sell |
| ADX (14) | 52.45 | Buy |
| Williams %R (14) | -4.57 | Sell |
| ATR (14) | 7.71 | Neutral |
| ROC (12) | 10.25 | Buy |
| Stoch RSI (14) | 65.31 | Neutral |
| UO (7,14,28) | 78.09 | Sell |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 8 January 2026 - Registrar confirms no dematerialisation/rematerialisation requests for 01.12.2025 to 31.12.2025. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 8 January 2026 - Registrar confirms no dematerialisation/rematerialisation requests for 01.12.2025 to 31.12.2025.](https://nsearchives.nseindia.com/corporate/SERVICECARE_08012026104802_Reg_74_5__Dec_2025_signed.pdf) |
| 8 December 2025 - Chairperson Shany Jalal received All India Achievers Foundation Outstanding Achievement Award in Delhi on 06-12-2025. | [Updates 8 December 2025 - Chairperson Shany Jalal received All India Achievers Foundation Outstanding Achievement Award in Delhi on 06-12-2025.](https://nsearchives.nseindia.com/corporate/SERVICECARE_08122025144724_Award_NSE_update.pdf) |
| 7h - Audited FY26 results approved; 3:2 bonus share record date fixed for 12 May 2026. | [Board Meeting Outcome for Outcome Of Board Meeting Held On 27Th April, 2026. 7h - Audited FY26 results approved; 3:2 bonus share record date fixed for 12 May 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/7685c73f-a903-46bf-8849-c8a37fa19d72.pdf) |
| 7h - Aptus Pharma says Regulation 24A and Annual Secretarial Compliance Report are not applicable. | [Disclosure Regarding Non-Applicability Of Regulation 24A Of SEBI (LODR) Regulations, 2015 7h - Aptus Pharma says Regulation 24A and Annual Secretarial Compliance Report are not applicable.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/739ff2a8-356f-482a-86ec-8218d645e31e.pdf) |
| 7 Feb - Of Investor Presentation under Regulation 30 of SEBI (LODR) Regulations, 2015 | [Announcement under Regulation 30 (LODR)-Investor Presentation 7 Feb - Of Investor Presentation under Regulation 30 of SEBI (LODR) Regulations, 2015](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ee6715a1-877d-4c1f-856d-d65eea91939f.pdf) |
| 6h - Record date fixed as 12 May 2026 for 3:2 bonus shares. | [Intimation Of Record Date For Issue Of Bonus Shares 6h - Record date fixed as 12 May 2026 for 3:2 bonus shares.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/92e7da05-acd0-4456-ac99-2caf088f2c6a.pdf) |
| 6h - Aptus Pharma approved FY26 audited results and fixed 12 May 2026 record date for 3:2 bonus shares. | [Audited Financial Results For The Half Year And Year Ended On 31St March, 2026 6h - Aptus Pharma approved FY26 audited results and fixed 12 May 2026 record date for 3:2 bonus shares.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/3673aaf0-8336-484a-9473-44f8719b6bdd.pdf) |
| 6 May - CARE report for half-year/year ended 31 March 2026 shows ₹13.02 crore IPO proceeds fully utilized, nil deviation. | [Announcement under Regulation 30 (LODR)-Monitoring Agency Report 6 May - CARE report for half-year/year ended 31 March 2026 shows ₹13.02 crore IPO proceeds fully utilized, nil deviation.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/a0bd234a-fa33-40b3-80ae-5e7f48cdbb0f.pdf) |
| 6 February 2026 - Certificate confirming no dematerialisation/rematerialisation requests received for 01.01.2026–31.01.2026. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 6 February 2026 - Certificate confirming no dematerialisation/rematerialisation requests received for 01.01.2026–31.01.2026.](https://nsearchives.nseindia.com/corporate/SERVICECARE_06022026130816_Reg_74_5__NSE_filing_Jan_26.pdf) |
| 4 February 2026 - Board met Feb 4, 2026; approved circular resolution dated Jan 16, 2026; no further details. | [Outcome of Board Meeting 4 February 2026 - Board met Feb 4, 2026; approved circular resolution dated Jan 16, 2026; no further details.](https://nsearchives.nseindia.com/corporate/SERVICECARE_04022026140316_BM_Outcome.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-09 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=30c9a2af-5f81-4ded-aba9-37ae61b6b8a1.pdf) |
| 2026-09-07 | [CORRIGENDUM / ADDENDUM TO NOTICE OF ANNUAL GENERAL MEETING AND E-VOTING](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4d45848-7103-4376-986a-789e1af44eb6.pdf) |
| 2026-08-24 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97522305-92b5-4276-b294-33467a41b957.pdf) |
| 2026-08-21 | [NOTICE OF ANNUAL GENERAL MEETING AND E-VOTING](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=919021ad-09ef-490f-a59d-8164aac7851f.pdf) |
| 2026-08-21 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e87ee3e-f117-4344-8773-1312a175fbe4.pdf) |
| 2026-08-17 | [Board Meeting Outcome for Outcome Of Board Meeting Dated 17.08.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61d88338-3d12-4743-b35e-95763c60a9fc.pdf) |
| 2026-08-12 | [Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On Monday August 17 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2dcb9958-d41d-4bf0-b386-bdc0890f536d.pdf) |
| 2026-08-10 | [Clarification Letter In Respect Of Outcome Of Board Meeting Held On 08.08.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1bd0c42d-7f71-466f-928b-ac3121d0a775.pdf) |
| 2026-08-08 | [Board Meeting Outcome for Outcome Of Board Meeting For Approval Of Preferential Issue Of Shares](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f91062e2-16b6-40b8-9977-fc6af98fc9c2.pdf) |
| 2026-08-05 | [Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Saturday August 8 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9283b98a-e713-4b73-8a7f-79027196b8b6.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-21 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eac0693a-721c-4047-b9d9-7e80a1ee417f.pdf) |
| 2026-05-29 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e0a019b9-6065-4243-a0e1-77b8d2582f2c.pdf) |
| 2026-02-07 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee6715a1-877d-4c1f-856d-d65eea91939f.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e0a019b9-6065-4243-a0e1-77b8d2582f2c.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/e0a019b9-6065-4243-a0e1-77b8d2582f2c.pdf) |
| Aug 2024 | [Concall - Aug 2024](https://nsearchives.nseindia.com/corporate/SERVICE_20082024134940_SCLInvestorpresentation.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-04-27 | [Audited Financial Results For The Half Year And Year Ended On 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3673aaf0-8336-484a-9473-44f8719b6bdd.pdf) |
| 2025-11-11 | [Unaudited Financial Results For The Half Year Ended On 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8aad38a4-5864-4cca-b7aa-90132e52799a.pdf) |
| 2025-11-10 | [Unaudited Financial Results For The Half Year Ended On 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16e202e7-2835-46f4-92bb-bdaa2cb8ca28.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_27042_SERVICE_2024_2025_A_21072025141852.pdf) |
| from nse | [Financial Year 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_25397_SERVICE_2023_2024_0209202411359.pdf) |
| from nse | [Financial Year 2023 from nse](https://archives.nseindia.com/annual_reports/SME_AR_22903_SERVICE_2022_2023_23082023222238_08242023070000.zip) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:58:27.377Z.